Corpus Intelligence IC Memo — TRI-COUNTY MEMORIAL HOSPITAL INC. 2026-04-26 15:42 UTC
IC Memo — TRI-COUNTY MEMORIAL HOSPITAL INC.
Investment Committee Memorandum | WI | 25 beds | Grade C | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TRI-COUNTY MEMORIAL HOSPITAL INC.

CCN 521316 | TREMPEALEAU, WI | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TRI-COUNTY MEMORIAL HOSPITAL INC. is a 25-bed rural/critical access in TREMPEALEAU, WI with $25.4M in net patient revenue and a -1.8% operating margin. The hospital serves a payer mix of 52.8% Medicare, 0.7% Medicaid, and 46.5% commercial.

Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.8% to 5.5% (+736bps).

Net Revenue HCRIS$25.4M
Current EBITDA COMPUTED$-460K
Operating Margin COMPUTED-1.8%
Occupancy HCRIS29.0%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS57.1%
Distress Probability ML56.2%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
87
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -1.8% places it below the state median. Among 87 size-comparable peers (12-50 beds), the median margin is 2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 87 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TRI-COUNTY MEMORIAL HOSPITAL (Target)WI25$25.4M-1.8%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
ASPIRUS RIVERVIEW HOSPITAL & CWI44$161.3M13.1%
MEMORIAL MEDICAL CENTER INC.WI25$138.4M8.1%
LAKEVIEW MEDICAL CENTER OF RICWI40$137.4M-12.0%
MARSHFIELD MEDICAL CENTER-MINOWI19$129.6M-12.4%
FORT ATKINSON MEMORIAL HOSPITAWI49$127.0M-10.1%
MCHS-RED CEDARWI25$123.4M16.8%
MEMORIAL HOSPITAL OF BURLINGTOWI33$118.8M15.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$533K+210bp18mo
Cost to Collect4.5%2.5%$507K+200bp12mo
Denial Rate Reduction12.0%6.5%$502K+198bp12mo
A/R Days Reduction5200.0%3800.0%$309K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$533K
Cost to Collect
$507K
Denial Rate Reduction
$502K
A/R Days Reduction
$309K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.9M
Current EBITDA$-460K
+ RCM Uplift+$1.9M
Pro Forma EBITDA$1.4M
Current Margin-1.8%
Pro Forma Margin5.5%
WC Released (1x)$973K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-708K$15.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-708K$17.0M0.00x-100.0%
Bull Case9.0x11.0x$-637K$22.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-637K$24.8M0.00x-100.0%
Bear Case11.0x10.0x$-779K$6.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-779K$6.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 29.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 56.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 87 hospitals with 12-50 beds
  • Same-state prioritization (n=88)
  • Comp margins: P25=-10.1% / P50=2.0% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.